Interaction between DMRT1 function and genetic background modulates signaling and pluripotency to control tumor susceptibility in the fetal germ line

Developmental Biology

Volumn 377, Issue 1, 2013, Pages 67-78

  Krentz, Anthony D ^a   Murphy, Mark W ^a   Zhang, Teng ^a   Sarver, Aaron L ^a   Jain, Sanjay ^b   Griswold, Michael D ^c   Bardwell, Vivian J ^a   Zarkower, David ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Dmrt1; Germ cell; Nanos3; Pluripotency; Teratoma; TGCT

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; PROTEIN NODAL; PROTEIN RET;

ANIMAL EXPERIMENT; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DMRT1 GENE; DNA METHYLATION; EMBRYO; FETUS; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LOSS; GENE MAPPING; GENE REPRESSION; GENE TARGETING; GERM CELL; GERM CELL TUMOR; HETEROZYGOSITY; HOMOZYGOSITY; MOUSE; NANOS3 GENE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; TESTIS; TRANSCRIPTION REGULATION;

ANIMALIA; MUS; VERTEBRATA;

EID: 84876342278     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2013.02.014     Document Type: Article

References (102)

1. Almstrup K., Hoei-Hansen C.E., Nielsen J.E., Wirkner U., Ansorge W., Skakkebaek N.E., Rajpert-De Meyts E., Leffers H. Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. Br. J. Cancer 2005, 92:1934-1941.
2. Baldassarre G., Romano A., Armenante F., Rambaldi M., Paoletti I., Sandomenico C., Pepe S., Staibano S., Salvatore G., De Rosa G., Persico M.G., Viglietto G. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene 1997, 15:927-936.
3. Beyrouthy M.J., Garner K.M., Hever M.P., Freemantle S.J., Eastman A., Dmitrovsky E., Spinella M.J. High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. Cancer Res. 2009, 69:9360-9366.
4. Bianco C., Rangel M.C., Castro N.P., Nagaoka T., Rollman K., Gonzales M., Salomon D.S. Role of Cripto-1 in stem cell maintenance and malignant progression. Am. J. Pathol. 2010, 177:532-540.
5. Blankenberg D., Gordon A., Von Kuster G., Coraor N., Taylor J., Nekrutenko A. Manipulation of FASTQ data with Galaxy. Bioinformatics 2010, 26:1783-1785.
6. Bowles J., Teasdale R.P., James K., Koopman P. Dppa3 is a marker of pluripotency and has a human homologue that is expressed in germ cell tumours. Cytogenet. Genome Res. 2003, 101:261-265.
7. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., Gifford D.K., Melton D.A., Jaenisch R., Young R.A. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
8. Caricasole A.A., van Schaik R.H., Zeinstra L.M., Wierikx C.D., van Gurp R.J., van den Pol M., Looijenga L.H., Oosterhuis J.W., Pera M.F., Ward A., de Bruijn D., Kramer P., de Jong F.H., van den Eijnden-van Raaij A.J. Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours. Oncogene 1998, 16:95-103.
9. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., Wong E., Orlov Y.L., Zhang W., Jiang J., Loh Y.H., Yeo H.C., Yeo Z.X., Narang V., Govindarajan K.R., Leong B., Shahab A., Ruan Y., Bourque G., Sung W.K., Clarke N.D., Wei C.L., Ng H.H. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
10. Ciccodicola A., Dono R., Obici S., Simeone A., Zollo M., Persico M.G. Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J. 1989, 8:1987-1991.
11. Clark A.T. The stem cell identity of testicular cancer. Stem Cell Rev. 2007, 3:49-59.
12. Clark A.T., Rodriguez R.T., Bodnar M.S., Abeyta M.J., Cedars M.I., Turek P.J., Firpo M.T., Reijo Pera R.A. Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells 2004, 22:169-179.
13. Cook M.S., Coveney D., Batchvarov I., Nadeau J.H., Capel B. BAX-mediated cell death affects early germ cell loss and incidence of testicular teratomas in Dnd1(Ter/Ter) mice. Dev. Biol. 2009, 328:377-383.
14. Cook M.S., Munger S.C., Nadeau J.H., Capel B. Regulation of male germ cell cycle arrest and differentiation by DND1 is modulated by genetic background. Development 2011, 138:23-32.
15. Durcova-Hills G., Capel B. Development of germ cells in the mouse. Curr. Top Dev. Biol. 2008, 83:185-212.
16. Fahrioglu U., Murphy M.W., Zarkower D., Bardwell V.J. mRNA expression analysis and the molecular basis of neonatal testis defects in Dmrt1 mutant mice. Sex Dev. 2007, 1:42-58.
17. Festuccia N., Osorno R., Halbritter F., Karwacki-Neisius V., Navarro P., Colby D., Wong F., Yates A., Tomlinson S.R., Chambers I. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 2012, 11:477-490.
18. Forman D., Oliver R.T., Brett A.R., Marsh S.G., Moses J.H., Bodmer J.G., Chilvers C.E., Pike M.C. Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br. J. Cancer 1992, 65:255-262.
19. Gao C., Pang L., Ren C., Ma T. Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient. Med. Oncol. 2012, 29:1733-1738.
20. Grande L., Bretones G., Rosa-Garrido M., Garrido-Martin E.M., Hernandez T., Fraile S., Botella L., de Alava E., Vidal A., Garcia del Muro X., Villanueva A., Delgado M.D., Fernandez-Luna J.L. Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin. J. Biol. Chem. 2012, 287:26495-26505.
21. Hackett J.A., Zylicz J.J., Surani M.A. Parallel mechanisms of epigenetic reprogramming in the germline. Trends Genet. 2012, 28:164-174.
22. Harrison N.J., Baker D., Andrews P.W. Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int. J. Androl. 2007, 30:275-281. discussion 281.
23. Hayashi Y., Hayashi M., Kobayashi S. Nanos suppresses somatic cell fate in Drosophila germ line. Proc. Nat. Acad. Sci. U.S.A. 2004, 101:10338-10342.
24. He S., Deng J., Li G., Wang B., Cao Y., Tu Y. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma. Jpn. J. Clin. Oncol. 2012, 42:196-201.
25. Heaney J.D., Anderson E.L., Michelson M.V., Zechel J.L., Conrad P.A., Page D.C., Nadeau J.H. Germ cell pluripotency, premature differentiation and susceptibility to testicular teratomas in mice. Development 2012, 139:1577-1586.
26. Heimdal K., Olsson H., Tretli S., Flodgren P., Borresen A.L., Fossa S.D. Familial testicular cancer in Norway and southern Sweden. Br. J. Cancer 1996, 73:964-969.
27. Heng J.C., Feng B., Han J., Jiang J., Kraus P., Ng J.H., Orlov Y.L., Huss M., Yang L., Lufkin T., Lim B., Ng H.H. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 2010, 6:167-174.
28. Hoei-Hansen C.E., Almstrup K., Nielsen J.E., Brask Sonne S., Graem N., Skakkebaek N.E., Leffers H., Rajpert-De Meyts E. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology 2005, 47:48-56.
29. Hofmann M.C. Gdnf signaling pathways within the mammalian spermatogonial stem cell niche. Mol. Cell. Endocrinol. 2008, 288:95-103.
30. Hu X.Y., Xu Y.M., Fu Q., Yu J.J., Huang J. Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia. Eur. J. Surg. Oncol. 2009, 35:527-531.
31. Jain S., Golden J.P., Wozniak D., Pehek E., Johnson E.M., Milbrandt J. RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice. J. Neurosci. 2006, 26:11230-11238.
32. Jain S., Naughton C.K., Yang M., Strickland A., Vij K., Encinas M., Golden J., Gupta A., Heuckeroth R., Johnson E.M., Milbrandt J. Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct role of Ret in spermatogenesis. Development 2004, 131:5503-5513.
33. James D., Levine A.J., Besser D., Hemmati-Brivanlou A. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005, 132:1273-1282.
34. Jameson S.A., Natarajan A., Cool J., DeFalco T., Maatouk D.M., Mork L., Munger S.C., Capel B. Temporal transcriptional profiling of somatic and germ cells reveals biased lineage priming of sexual fate in the fetal mouse gonad. PLoS Genet. 2012, 8:e1002575.
35. Jin V.X., Apostolos J., Nagisetty N.S., Farnham P.J. W-ChIPMotifs: a web application tool for de novo motif discovery from ChIP-based high-throughput data. Bioinformatics 2009, 25:3191-3193.
36. Jones T.D., Ulbright T.M., Eble J.N., Baldridge L.A., Cheng L. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am. J. Surg. Pathol. 2004, 28:935-940.
37. Kanetsky P.A., Mitra N., Vardhanabhuti S., Li M., Vaughn D.J., Letrero R., Ciosek S.L., Doody D.R., Smith L.M., Weaver J., Albano A., Chen C., Starr J.R., Rader D.J., Godwin A.K., Reilly M.P., Hakonarson H., Schwartz S.M., Nathanson K.L. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat. Genet. 2009, 41:811-815.
38. Kanetsky, P.A., Mitra, N., Vardhanabhuti, S., Vaughn, D.J., Li, M., Ciosek, S.L., Letrero, R., D'Andrea, K., Vaddi, M., Doody, D.R., Weaver, J., Chen, C., Starr, J.R., Hakonarson, H., Rader, D.J., Godwin, A.K., Reilly, M.P., Schwartz, S.M., Nathanson, K.L., 2011. A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Hum. Mol. Genet.
39. Kelly R.K., Olson D.L., Sun Y., Wen D., Wortham K.A., Antognetti G., Cheung A.E., Orozco O.E., Yang L., Bailly V., Sanicola M. An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours. Eur. J. Cancer 2011, 47:1736-1746.
40. Kidder B.L., Palmer S. Examination of transcriptional networks reveals an important role for TCFAP2C, SMARCA4, and EOMES in trophoblast stem cell maintenance. Genome Res. 2010, 20:458-472.
41. Kim J., Orkin S.H. Embryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicine. Genome Med. 2011, 3:75.
42. Kim S., Bardwell V.J., Zarkower D. Cell type-autonomous and non-autonomous requirements for Dmrt1 in postnatal testis differentiation. Dev. Biol. 2007, 307:314-327.
43. Kim S.K., Suh M.R., Yoon H.S., Lee J.B., Oh S.K., Moon S.Y., Moon S.H., Lee J.Y., Hwang J.H., Cho W.J., Kim K.S. Identification of developmental pluripotency associated 5 expression in human pluripotent stem cells. Stem Cells 2005, 23:458-462.
44. Kimura T., Suzuki A., Fujita Y., Yomogida K., Lomeli H., Asada N., Ikeuchi M., Nagy A., Mak T.W., Nakano T. Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 2003, 130:1691-1700.
45. Koo B.K., Spit M., Jordens I., Low T.Y., Stange D.E., van de Wetering M., van Es J.H., Mohammed S., Heck A.J., Maurice M.M., Clevers H. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 2012, 488:665-669.
46. Krentz A.D., Murphy M.W., Kim S., Cook M.S., Capel B., Zhu R., Matin A., Sarver A.L., Parker K.L., Griswold M.D., Looijenga L.H., Bardwell V.J., Zarkower D. The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. Proc. Nat. Acad. Sci. U.S.A. 2009, 106:22323-22328.
47. Krentz A.D., Murphy M.W., Sarver A.L., Griswold M.D., Bardwell V.J., Zarkower D. DMRT1 promotes oogenesis by transcriptional activation of Stra8 in the mammalian fetal ovary. Dev. Biol. 2011, 356:63-70.
48. La Salle S., Oakes C.C., Neaga O.R., Bourc'his D., Bestor T.H., Trasler J.M. Loss of spermatogonia and wide-spread DNA methylation defects in newborn male mice deficient in DNMT3L. BMC Dev. Biol. 2007, 7:104.
49. Lam M.Y., Nadeau J.H. Genetic control of susceptibility to spontaneous testicular germ cell tumors in mice. APMIS 2003, 111:184-190. discussion 191.
50. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10:R25.
51. Lei N., Hornbaker K.I., Rice D.A., Karpova T., Agbor V.A., Heckert L.L. Sex-specific differences in mouse DMRT1 expression are both cell type- and stage-dependent during gonad development. Biol. Reprod. 2007, 77:466-475.
52. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., Nery J.R., Lee L., Ye Z., Ngo Q.M., Edsall L., Antosiewicz-Bourget J., Stewart R., Ruotti V., Millar A.H., Thomson J.A., Ren B., Ecker J.R. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
53. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., Bourque G., George J., Leong B., Liu J., Wong K.Y., Sung K.W., Lee C.W., Zhao X.D., Chiu K.P., Lipovich L., Kuznetsov V.A., Robson P., Stanton L.W., Wei C.L., Ruan Y., Lim B., Ng H.H. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 2006, 38:431-440.
54. Looijenga L.H., Gillis A.J., Stoop H.J., Hersmus R., Oosterhuis J.W. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis. Ann. N.Y. Acad. Sci. 2007, 1120:187-214.
55. Maldonado-Saldivia J., van den Bergen J., Krouskos M., Gilchrist M., Lee C., Li R., Sinclair A.H., Surani M.A., Western P.S. Dppa2 and Dppa4 are closely linked SAP motif genes restricted to pluripotent cells and the germ line. Stem Cells 2007, 25(19-28).
56. Masui S., Nakatake Y., Toyooka Y., Shimosato D., Yagi R., Takahashi K., Okochi H., Okuda A., Matoba R., Sharov A.A., Ko M.S., Niwa H. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 2007, 9:625-635.
57. Matson C.K., Murphy M.W., Griswold M.D., Yoshida S., Bardwell V.J., Zarkower D. The mammalian doublesex homolog DMRT1 is a transcriptional gatekeeper that controls the mitosis versus meiosis decision in male germ cells. Dev. Cell. 2010, 19:612-624.
58. Matson C.K., Murphy M.W., Sarver A.L., Griswold M.D., Bardwell V.J., Zarkower D. DMRT1 prevents female reprogramming in the postnatal mammalian testis. Nature 2011, 476:101-104.
59. Matson C.K., Zarkower D. Sex and the singular DM domain: insights into sexual regulation, evolution and plasticity. Nat. Rev. Genet. 2012, 13:163-174.
60. Miles D.C., van den Bergen J.A., Wakeling S.I., Anderson R.B., Sinclair A.H., Western P.S. The proto-oncogene Ret is required for male foetal germ cell survival. Dev. Biol. 2012, 365:101-109.
61. Minami K., Chano T., Kawakami T., Ushida H., Kushima R., Okabe H., Okada Y., Okamoto K. DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma. Clin Cancer Res. 2010, 16:2751-2759.
62. Munger S.C., Aylor D.L., Syed H.A., Magwene P.M., Threadgill D.W., Capel B. Elucidation of the transcription network governing mammalian sex determination by exploiting strain-specific susceptibility to sex reversal. Genes. Dev. 2009, 23:2521-2536.
63. Murphy M.W., Sarver A.L., Rice D., Hatzi K., Ye K., Melnick A., Heckert L.L., Zarkower D., Bardwell V.J. Genome-wide analysis of DNA binding and transcriptional regulation by the mammalian Doublesex homolog DMRT1 in the juvenile testis. Proc. Nat. Acad. Sci. U.S.A. 2010, in press.
64. Murphy M.W., Zarkower D., Bardwell V.J. Vertebrate DM domain proteins bind similar DNA sequences and can heterodimerize on DNA. BMC Mol. Biol. 2007, 8:58.
65. Narva E., Rahkonen N., Emani M.R., Lund R., Pursiheimo J.P., Nasti J., Autio R., Rasool O., Denessiouk K., Lahdesmaki H., Rao A., Lahesmaa R. RNA-binding protein L1TD1 interacts with LIN28 via RNA and is required for human embryonic stem cell self-renewal and cancer cell proliferation. Stem Cells 2012, 30:452-460.
66. Naughton C.K., Jain S., Strickland A.M., Gupta A., Milbrandt J. Glial cell-line derived neurotrophic factor-mediated RET signaling regulates spermatogonial stem cell fate. Biol. Reprod. 2006, 74:314-321.
67. Oberley M.J., Tsao J., Yau P., Farnham P.J. High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol. 2004, 376:315-334.
68. Oosterhuis J.W., Looijenga L.H. Testicular germ-cell tumours in a broader perspective. Nat. Rev. Cancer 2005, 5:210-222.
69. Pinheiro I., Margueron R., Shukeir N., Eisold M., Fritzsch C., Richter F.M., Mittler G., Genoud C., Goyama S., Kurokawa M., Son J., Reinberg D., Lachner M., Jenuwein T. Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. Cell 2012, 150:948-960.
70. Rajpert-De Meyts E., Hanstein R., Jorgensen N., Graem N., Vogt P.H., Skakkebaek N.E. Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum. Reprod. 2004, 19:1338-1344.
71. Rapley E.A., Turnbull C., Al Olama A.A., Dermitzakis E.T., Linger R., Huddart R.A., Renwick A., Hughes D., Hines S., Seal S., Morrison J., Nsengimana J., Deloukas P., Rahman N., Bishop D.T., Easton D.F., Stratton M.R. A genome-wide association study of testicular germ cell tumor. Nat. Genet. 2009, 41:807-810.
72. Raymond C.S., Kettlewell J.R., Hirsch B., Bardwell V.J., Zarkower D. Expression of Dmrt1 in the genital ridge of mouse and chicken embryos suggests a role in vertebrate sexual development. Dev. Biol. 1999, 215:208-220.
73. Raymond C.S., Murphy M.W., O'Sullivan M.G., Bardwell V.J., Zarkower D. Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation. Genes. Dev. 2000, 14:2587-2595.
74. Regenass U., Friedrich T.D., Stevens L.C. Experimental induction of testicular teratomas in dissociated-reaggregated chimaeric gonads. J. Embryol. Exp. Morphol. 1982, 72:153-167.
75. Richards M., Tan S.P., Tan J.H., Chan W.K., Bongso A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 2004, 22:51-64.
76. Schafer, S., Anschlag, J., Nettersheim, D., Haas, N., Pawig, L., Schorle, H., 2011. The role of BLIMP1 and its putative downstream target TFAP2C in germ cell development and germ cell tumours. Int. J. Androl.
77. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Prot. 2008, 3:1101-1108.
78. Sharov A.A., Masui S., Sharova L.V., Piao Y., Aiba K., Matoba R., Xin L., Niwa H., Ko M.S. Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data. BMC Genomics 2008, 9:269.
79. Shen M.M. Nodal signaling: developmental roles and regulation. Development 2007, 134:1023-1034.
80. Small C.L., Shima J.E., Uzumcu M., Skinner M.K., Griswold M.D. Profiling gene expression during the differentiation and development of the murine embryonic gonad. Biol. Reprod. 2005, 72:492-501.
81. Spiller C.M., Feng C.W., Jackson A., Gillis A.J., Rolland A.D., Looijenga L.H., Koopman P., Bowles J. Endogenous Nodal signaling regulates germ cell potency during mammalian testis development. Development 2012.
82. Stevens L.C. Experimental production of testicular teratomas in mice. Proc. Nat. Acad. Sci. U.S.A. 1964, 52:654-661.
83. Stevens L.C. Development of resistance to teratocarcinogenesis by primordial germ cells in mice. J. Nat. Cancer Inst. 1966, 37:859-867.
84. Stevens L.C. A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas. J. Nat. Cancer Inst. 1973, 50:235-242.
85. Stevens L.C., Little C.C. Spontaneous testicular teratomas in an inbred strain of mice. Proc. Nat. Acad. Sci. U.S.A. 1954, 40:1080-1087.
86. Suzuki H., Tsuda M., Kiso M., Saga Y. Nanos3 maintains the germ cell lineage in the mouse by suppressing both Bax-dependent and -independent apoptotic pathways. Dev. Biol. 2008, 318:133-142.
87. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
88. Tsuda M., Sasaoka Y., Kiso M., Abe K., Haraguchi S., Kobayashi S., Saga Y. Conserved role of nanos proteins in germ cell development. Science 2003, 301:1239-1241.
89. Turnbull C., Rapley E.A., Seal S., Pernet D., Renwick A., Hughes D., Ricketts M., Linger R., Nsengimana J., Deloukas P., Huddart R.A., Bishop D.T., Easton D.F., Stratton M.R., Rahman N. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat. Genet. 2010, 42:604-607.
90. Uesaka T., Jain S., Yonemura S., Uchiyama Y., Milbrandt J., Enomoto H. Conditional ablation of GFRalpha1 in postmigratory enteric neurons triggers unconventional neuronal death in the colon and causes a Hirschsprung's disease phenotype. Development 2007, 134:2171-2181.
91. Vallier L., Alexander M., Pedersen R.A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 2005, 118:4495-4509.
92. Vallier L., Reynolds D., Pedersen R.A. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev. Biol. 2004, 275:403-421.
93. Wang W., Yang J., Liu H., Lu D., Chen X., Zenonos Z., Campos L.S., Rad R., Guo G., Zhang S., Bradley A., Liu P. Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc. Nat. Acad. Sci. U.S.A. 2011.
94. Weber S., Eckert D., Nettersheim D., Gillis A.J., Schafer S., Kuckenberg P., Ehlermann J., Werling U., Biermann K., Looijenga L.H., Schorle H. Critical function of AP-2 gamma/TCFAP2C in mouse embryonic germ cell maintenance. Biol. Reprod. 2010, 82:214-223.
95. Western P.S., van den Bergen J.A., Miles D.C., Sinclair A.H. Male fetal germ cell differentiation involves complex repression of the regulatory network controlling pluripotency. FASEB J. 2010, 24:3026-3035.
96. Woodfield G.W., Chen Y., Bair T.B., Domann F.E., Weigel R.J. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells. Genes Chromosom. Cancer 2010, 49:948-962.
97. Yamaguchi S., Kimura H., Tada M., Nakatsuji N., Tada T. Nanog expression in mouse germ cell development. Gene. Expr. Patterns 2005, 5:639-646.
98. Yang J., Gao C., Chai L., Ma Y. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS One 2010, 5:e10766.
99. Youngren K.K., Coveney D., Peng X., Bhattacharya C., Schmidt L.S., Nickerson M.L., Lamb B.T., Deng J.M., Behringer R.R., Capel B., Rubin E.M., Nadeau J.H., Matin A. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 2005, 435:360-364.
100. Youngren K.K., Nadeau J.H., Matin A. Testicular cancer susceptibility in the 129.MOLF-Chr19 mouse strain: additive effects, gene interactions and epigenetic modifications. Hum. Mol. Genet. 2003, 12:389-398.
101. Yuan H., Corbi N., Basilico C., Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 1995, 9:2635-2645.
102. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., Nusbaum C., Myers R.M., Brown M., Li W., Liu X.S. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008, 9:R137.